ADGM.US Adagio Medical Holdings, Inc Common Stock

Healthcare Pharmaceuticals USA Stocks
1.82 USD
Close of Nov 13, 2026
1.50 50.70
Market cap
USD 49.9M
P/E
-
P/B
2.89x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ADGM.US undervalued?

Graham number

The Graham number of Adagio Medical Holdings, Inc Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Adagio Medical Holdings, Inc Common Stock fundamental analysis

No fundamental analysis for Adagio Medical Holdings, Inc Common Stock yet.

Adagio Medical Holdings, Inc Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Adagio Medical Holdings, Inc Common Stock

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. …

Full company profile